Wilms tumours with blastemal predominance are positive for CD56, CD57, and WT1 in the great majority of patients, although the findings must be distinguished from lymphomas, sarcomas, or less likely metastases from other regions. This evidence concerns the gene NCAM1 and sarcoma.